ALPL, CLCN7, COL10A1, COL1A1, COL1A2, COL2A1, COMP, DYNC2H1, DYNC2I1, DYNC2I2, FGFR3, FLNA, HSPG2, IFT80, PCNT, SLC26A2, SOX9, TRPV4
- DYNC2H1 was previously WDR60
- DYNC2I2 was previously WDR30
Lab:
TAT:
35 days
Price:
$2,500
CPT Code(s):
81479
Test Code:
DSDP
Prenatal Samples Accepted
The Skeletal Dysplasia NGS Panel is an 11-gene panel intended for patients with a diagnosis or clinical suspicion of a skeletal dysplasia.
Achondrogenesis type IB, Achondroplasia, Arthrochalasia Ehlers-Danlos syndrome, Brachyolmia, Campomelic dysplasia, Dyssegmental dysplasia, Silverman-Handmaker type, Frontometaphyseal dysplasia, Hypophosphatasia, Metaphyseal chondrodysplasia, Schmid type, Metatropic dysplasia, Microcephalic osteodysplastic primordial dwarfism, Odontohypophosphatasia, Parastremmatic dwarfism, Pseudoachondroplasia, Scapuloperoneal myopathy, Spondyloepiphyseal dysplasia (SED), Maroteaux type, Short-rib thoracic dysplasia
Skeletal dysplasias make up a large and diverse group of disorders. A diagnosis is often based on a combination of clinical, radiological, and molecular findings. There is a great deal of phenotypic overlap and genetic heterogeneity among skeletal dysplasias. The 11 genes included on this panel account for more than 30 distinct clinical phenotypes.
This panel is performed by Next Generation Sequencing and covers the coding regions of the listed genes and the flanking intronic sequences. Promoter, 3′ untranslated sequences, and deep intronic sequences are also covered, but only known disease-causing variants in these regions will be reported. Variants identified on the panel are confirmed with Sanger sequencing if they do not meet certain quality thresholds. Large deletions and duplications (CNVs) affecting the genes of the panel can be detected; however, due to defined settings in the analysis software, CNVs smaller than 2-kb may not be identified (for example, some small exonic level copy number changes may not be identified). Please note that certain types of genetic alterations including trinucleotide repeat expansions, methylation abnormalities, and balanced rearrangements (e.g., inversions, reciprocal translocations) may not be detected by the current analysis.
This panel can be used for prenatal samples if abnormal skeletal findings are present on ultrasound. Additional fees for cell culture and maternal cell contamination may apply. Maternal cell contamination studies are required for all prenatal molecular tests. Contact the laboratory prior to sending a prenatal specimen.
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC